Pricing Log in Create free account

Calidi Biotherapeutics, Inc. (CLDI) vs Panbela Therapeutics Inc. (PBLA)

Calidi Biotherapeutics, Inc. and Panbela Therapeutics Inc. are both Biotechnology companies. Calidi Biotherapeutics, Inc. and Panbela Therapeutics Inc. are of similar size ($3.4M and $3.2M). Across the 8 metrics below, Panbela Therapeutics Inc. leads on 6 and Calidi Biotherapeutics, Inc. on 2.

Valuation

Metric CLDI PBLA Biotechnology median
P/E n/m n/m 8.50
P/S n/m n/m 9.71
P/B 0.38 n/m 2.13
Price to free cash flow n/m n/m 20.82
EV/EBITDA 0.07 n/m 0.64
EV/Sales n/m n/m 9.21
Earnings yield (6,464.29%) 0.00% (33.15%)
Free cash flow yield (1,500.29%) 0.00% (25.50%)

Profitability

Metric CLDI PBLA Biotechnology median
Gross margin — — 65.16%
Operating margin 0.00% 0.00% 0.00%
Net margin 0.00% 0.00% 0.00%
Free cash flow margin 0.00% 0.00% 0.00%
Return on equity (900.56%) 270.37% (56.36%)
Return on assets (283.36%) (353.47%) (48.04%)
Return on invested capital 0.00% 0.00% 0.00%

Growth

Metric CLDI PBLA Biotechnology median
Revenue growth (TTM) — — 6.02%
EPS growth (last fiscal year) 83.31% 99.43% 30.26%
Revenue growth, 5-year CAGR — — 9.41%
Net income growth, 5-year CAGR — 0.00% 0.00%

Health

Metric CLDI PBLA Biotechnology median
Debt to equity 0.24 (0.23) 0.00
Current ratio 1.68 0.26 4.72
Net debt to EBITDA 0.26 (0.10) 0.96

Dividend

Metric CLDI PBLA Biotechnology median
Dividend yield — — 0.09%
Payout ratio — — —

Size

Metric CLDI PBLA Biotechnology median
Market cap 3.20m 3.35m 135.18m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack